Unsere Internetseite verwendet Cookies. Indem Sie weiter auf unserer Website navigieren, stimmen Sie der Verwendung von Cookies zu. Mehr Informationen finden Sie in unserer Datenschutzerklärung.

Pressemitteilungen

Gen Re Releases 2017 U.S. Individual Disability Market Survey Results

Ausgabe: May 2018 | Life/Health North America

For immediate release
May 2, 2018

Portland, ME, May 2, 2018 … Gen Re’s recently released U.S. Individual Disability Market Survey reveals overall positive results in 2017 for the 15 participating companies. Total in-force premium, which includes Non-Cancelable (Non-Can), Guaranteed Renewable (GR) and Buy-Sell products, increased 2.3%, representing $4.7 billion. Meanwhile, total sales premium increased 9.1%, reaching $402 million.

Additional highlights from this annual benchmark report include:

  • Non-Can in-force premium increased 2.1% to $4 billion and represents 85% of total in-force premium. GR in-force premium grew 4.4% to $623 million while Buy-Sell fell 2.5% to under $60 million.
  • Non-Can and GR sales premium grew 9.3% and 8.4%, respectively, while Buy-Sell sales premium increased 6.4%.
  • The total number of in-force policies remained level, increasing less than one percent (0.8%). However, total new policies increased 9.6%, due mainly to an uptick of nearly 23% in GR policies.
 

The Market Survey is an annual benchmark survey produced by Gen Re, with the full results available only to participating companies. A summary report is available online at genre.com/lhsurveys.

________________________

Gen Re, a Berkshire Hathaway Company, is one of the leading life/health and property/casualty reinsurers in the world. Our North American life and health reinsurance company, General Re Life Corporation, has superior financial strength ratings among life and health reinsurers. Gen Re delivers tailor-made reinsurance programs and risk management solutions for the Life, AD&D, Medicare Supplement, Critical Illness and Disability markets. Through our research, we also offer valuable information and insights. For more information, visit www.genre.com.

 

Contact:

Steve Woods
Tel. + 207 347 4621